However, a follow-up period longer than one year identified that BBB disruption is restricted to a particular clinical phenotype linked with cognitive impairment and related to systemic inflammation providing TGFβ as a biomarker related to the degree of BBB disruption. The gene discussed is TGFB1; the disease is Cognitive impairment.